Repligen Corporation · NASDAQ:RGEN
T. Rowe Price Associates Inc reported a 8.20% stake in Repligen Corporation (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
T. Rowe Price Associates Inc reported a 8.20% stake in Repligen Corporation, 4,599,860 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 8.20%
- Shares
- 4,599,860
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 8.20% | 4,599,860 |
Source
Related
- Repligen Corporation
- T. Rowe Price Associates Inc
- Repligen Corporation shareholders
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2025
- Schedule 13G/A · T. Rowe Price Associates Inc · Feb 14, 2025
- Form 4 · Douglass Brian Robb · Oct 8, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Loeillot Olivier · Oct 6, 2026
- Form 4 · Loeillot Olivier · Oct 5, 2026
- Form 4 · Garland Jason K · Sep 28, 2026